Author

Aditi Saha

Institutions: Moffitt Cancer Center, University of Alabama at Birmingham, UAB Medicine

Observed institutions: Moffitt Cancer Center, University of Alabama at Birmingham, UAB Medicine

ORCID: 0000-0003-3421-3971

Observed ORCID: 0000-0003-3421-3971

OpenAlex ID: A5148743707

Treatment-related outcomes and patterns of relapse in secondary CNS involvement by large B-cell lymphoma

2026 · Juan Pablo Alderuccio, Diva Baggio, et al. · Blood · 7

Systemic Xanthogranuloma or Erdheim–Chester disease: A systematic review re‐examining the classification challenge

2026 · Vyshnavi Rallapalle, Sailesh I. S. Kumar, et al. · British Journal of Haematology · 1

POSTER: CT-531: Outpatient CAR-T Therapy for Relapsed/Refractory Lymphoma: A Single-Center Experience

2026 · Aditi Saha, Sally Jones, et al. · Clinical Lymphoma Myeloma & Leukemia

TCL-727: A Phase 1 Dose-Finding Study of Mogamulizumab in Combination With Brentuximab Vedotin in Previously Treated Mycosis Fungoides and Sézary Syndrome

2026 · Lauren Shea, Lauren Hughey, et al. · Clinical Lymphoma Myeloma & Leukemia

TCL-302: The Role of Frontline Hematopoietic Stem Cell Transplantation in Peripheral T-Cell Lymphoma-Not Otherwise Specified

2026 · Firas Baidoun, Mahmood Aldapt, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: TCL-727: A Phase 1 Dose-Finding Study of Mogamulizumab in Combination With Brentuximab Vedotin in Previously Treated Mycosis Fungoides and Sézary Syndrome

2026 · Lauren Shea, Lauren Hughey, et al. · Clinical Lymphoma Myeloma & Leukemia

CT-531: Outpatient CAR-T Therapy for Relapsed/Refractory Lymphoma: A Single-Center Experience

2026 · Aditi Saha, Sally Jones, et al. · Clinical Lymphoma Myeloma & Leukemia

MPN-1280: KRAS Mutations in Histiocytic Neoplasms: Mutation Spectrum and Response to MEK Inhibition

2026 · Dongni Yi, Carla Borre, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: TCL-302: The Role of Frontline Hematopoietic Stem Cell Transplantation in Peripheral T-Cell Lymphoma-Not Otherwise Specified

2026 · Firas Baidoun, Mahmood Aldapt, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: MCL-906: Real-World Outcomes of Lisocabtagene Maraleucel in Patients With Relapsed and/or Refractory Mantle Cell Lymphoma

2026 · Sally Jones, Hanan Alharthy, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: MPN-1280: KRAS Mutations in Histiocytic Neoplasms: Mutation Spectrum and Response to MEK Inhibition

2026 · Dongni Yi, Carla Borre, et al. · Clinical Lymphoma Myeloma & Leukemia

MCL-906: Real-World Outcomes of Lisocabtagene Maraleucel in Patients With Relapsed and/or Refractory Mantle Cell Lymphoma

2026 · Sally Jones, Hanan Alharthy, et al. · Clinical Lymphoma Myeloma & Leukemia

Works count: 12

Citation count: 8

H-index: 1

I10-index: